{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:09:31Z","timestamp":1791461371871,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nonalcoholic fatty liver disease (NAFLD) is a global health problem that is associated with various metabolic disorders. Telmisartan is a potential treatment for NAFLD due to its ability to improve insulin sensitivity and decrease hepatic fat accumulation via modulation of PPAR\u03b3, and to suppress hepatic fibrosis by blocking angiotensin II receptors. However, the underlying mechanisms of action of telmisartan have yet to be fully elucidated. In the present study, diabetic nonalcoholic steatohepatitis (NASH) mice (STAM mice) received daily administrations of telmisartan for 6 weeks to assess the improvements in NASH. Hepatic transcriptome analyses revealed that the amelioration of NASH likely occurred through the regulation of inflammatory- and fibrosis-related gene responses. An integrated network analysis including transcriptional and non-transcriptional genes regulated by telmisartan showed that the NAFLD pathway is interconnected with the dysregulated RAS-PPAR-NF\u03baB pathways. The downstream targets of PPAR\u03b1, PPAR\u03b4, and RELA in this network significantly overlapped with telmisartan-induced differentially expressed genes (DEGs), which were verified in palmitate-treated Hepa1c1c7 cell line. This transcriptome approach accompanied with cell-based molecular analyses provided the opportunity to understand the fundamental molecular mechanisms underpinning the therapeutic effects of telmisartan, and will contribute to the establishment of a novel pharmacological treatment for NASH patients.<\/jats:p>","DOI":"10.1038\/s41598-019-40322-1","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T06:03:45Z","timestamp":1552025025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan"],"prefix":"10.1038","volume":"9","author":[{"given":"Jung Gyu","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Soo","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young In","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Sub","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keon Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol Soo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Dong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonghoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"key":"40322_CR1","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1467-789X.2009.00657.x","volume":"11","author":"G Musso","year":"2010","unstructured":"Musso, G., Gambino, R. & Cassader, M. Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obesity reviews: an official journal of the International Association for the Study of Obesity 11, 430\u2013445, https:\/\/doi.org\/10.1111\/j.1467-789X.2009.00657.x (2010).","journal-title":"Obesity reviews: an official journal of the International Association for the Study of Obesity"},{"key":"40322_CR2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jhep.2008.10.010","volume":"50","author":"JG Fan","year":"2009","unstructured":"Fan, J. G. & Farrell, G. C. Epidemiology of non-alcoholic fatty liver disease in China. Journal of hepatology 50, 204\u2013210, https:\/\/doi.org\/10.1016\/j.jhep.2008.10.010 (2009).","journal-title":"Journal of hepatology"},{"key":"40322_CR3","doi-asserted-by":"publisher","unstructured":"Caligiuri, A., Gentilini, A. & Marra, F. Molecular Pathogenesis of NASH. International journal of molecular sciences 17, https:\/\/doi.org\/10.3390\/ijms17091575 (2016).","DOI":"10.3390\/ijms17091575"},{"key":"40322_CR4","doi-asserted-by":"publisher","unstructured":"Lefebvre, P. et al. Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARalpha-regulated dermatopontin. JCI insight 2, https:\/\/doi.org\/10.1172\/jci.insight.92264 (2017).","DOI":"10.1172\/jci.insight.92264"},{"key":"40322_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/hep.23521","volume":"51","author":"P Angulo","year":"2010","unstructured":"Angulo, P. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 51, 373\u2013375, https:\/\/doi.org\/10.1002\/hep.23521 (2010).","journal-title":"Hepatology"},{"key":"40322_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams, L. A. et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113\u2013121 (2005).","journal-title":"Gastroenterology"},{"key":"40322_CR7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day, C. P. & James, O. F. Steatohepatitis: a tale of two \u201chits\u201d? Gastroenterology 114, 842\u2013845 (1998).","journal-title":"Gastroenterology"},{"key":"40322_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/hep.26661","volume":"59","author":"CA Moylan","year":"2014","unstructured":"Moylan, C. A. et al. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatology 59, 471\u2013482, https:\/\/doi.org\/10.1002\/hep.26661 (2014).","journal-title":"Hepatology"},{"key":"40322_CR9","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1053\/j.gastro.2013.07.047","volume":"145","author":"SK Murphy","year":"2013","unstructured":"Murphy, S. K. et al. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. Gastroenterology 145, 1076\u20131087, https:\/\/doi.org\/10.1053\/j.gastro.2013.07.047 (2013).","journal-title":"Gastroenterology"},{"key":"40322_CR10","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.cgh.2008.08.012","volume":"6","author":"RR Mummadi","year":"2008","unstructured":"Mummadi, R. R., Kasturi, K. S., Chennareddygari, S. & Sood, G. K. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association 6, 1396\u20131402, https:\/\/doi.org\/10.1016\/j.cgh.2008.08.012 (2008).","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"key":"40322_CR11","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1111\/liv.13131","volume":"36","author":"Y Wu","year":"2016","unstructured":"Wu, Y. et al. Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease. Liver international: official journal of the International Association for the Study of the Liver 36, 1525\u20131534, https:\/\/doi.org\/10.1111\/liv.13131 (2016).","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"key":"40322_CR12","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.3748\/wjg.15.2579","volume":"15","author":"RM Pereira","year":"2009","unstructured":"Pereira, R. M., dos Santos, R. A., da Costa Dias, F. L., Teixeira, M. M. & Simoes e Silva, A. C. Renin-angiotensin system in the pathogenesis of liver fibrosis. World journal of gastroenterology 15, 2579\u20132586 (2009).","journal-title":"World journal of gastroenterology"},{"key":"40322_CR13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1161\/01.HYP.0000215181.60228.f7","volume":"47","author":"K Sugimoto","year":"2006","unstructured":"Sugimoto, K. et al. Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis. Hypertension 47, 1003\u20131009, https:\/\/doi.org\/10.1161\/01.HYP.0000215181.60228.f7 (2006).","journal-title":"Hypertension"},{"key":"40322_CR14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","volume":"43","author":"SC Benson","year":"2004","unstructured":"Benson, S. C. et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 43, 993\u20131002, https:\/\/doi.org\/10.1161\/01.HYP.0000123072.34629.57 (2004).","journal-title":"Hypertension"},{"key":"40322_CR15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3748\/wjg.v12.i2.322","volume":"12","author":"S Yokohama","year":"2006","unstructured":"Yokohama, S. et al. Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis. World journal of gastroenterology 12, 322\u2013326 (2006).","journal-title":"World journal of gastroenterology"},{"key":"40322_CR16","doi-asserted-by":"publisher","first-page":"587140","DOI":"10.1155\/2013\/587140","volume":"2013","author":"T Hirata","year":"2013","unstructured":"Hirata, T. et al. Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY). International journal of endocrinology 2013, 587140, https:\/\/doi.org\/10.1155\/2013\/587140 (2013).","journal-title":"International journal of endocrinology"},{"key":"40322_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/1319-3767.173762","volume":"22","author":"S Alam","year":"2016","unstructured":"Alam, S. et al. Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial. Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association 22, 69\u201376, https:\/\/doi.org\/10.4103\/1319-3767.173762 (2016).","journal-title":"Saudi journal of gastroenterology: official journal of the Saudi Gastroenterology Association"},{"key":"40322_CR18","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1007\/s10620-007-9741-4","volume":"52","author":"K Fujita","year":"2007","unstructured":"Fujita, K. et al. Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats. Digestive diseases and sciences 52, 3455\u20133464, https:\/\/doi.org\/10.1007\/s10620-007-9741-4 (2007).","journal-title":"Digestive diseases and sciences"},{"key":"40322_CR19","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3892\/mmr.2013.1714","volume":"8","author":"E Fuentes","year":"2013","unstructured":"Fuentes, E., Guzman-Jofre, L., Moore-Carrasco, R. & Palomo, I. Role of PPARs in inflammatory processes associated with metabolic syndrome (Review). Molecular medicine reports 8, 1611\u20131616, https:\/\/doi.org\/10.3892\/mmr.2013.1714 (2013).","journal-title":"Molecular medicine reports"},{"key":"40322_CR20","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","volume":"109","author":"M Schupp","year":"2004","unstructured":"Schupp, M., Janke, J., Clasen, R., Unger, T. & Kintscher, U. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 109, 2054\u20132057, https:\/\/doi.org\/10.1161\/01.CIR.0000127955.36250.65 (2004).","journal-title":"Circulation"},{"key":"40322_CR21","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1097\/00004872-200412000-00003","volume":"22","author":"TW Kurtz","year":"2004","unstructured":"Kurtz, T. W. & Pravenec, M. Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system. Journal of hypertension 22, 2253\u20132261 (2004).","journal-title":"Journal of hypertension"},{"key":"40322_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1600-0463.2011.02746.x","volume":"119","author":"C Soderberg","year":"2011","unstructured":"Soderberg, C. et al. Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 119, 412\u2013420, https:\/\/doi.org\/10.1111\/j.1600-0463.2011.02746.x (2011).","journal-title":"APMIS: acta pathologica, microbiologica, et immunologica Scandinavica"},{"key":"40322_CR23","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1111\/j.1530-0277.2006.00292.x","volume":"31","author":"S Ito","year":"2007","unstructured":"Ito, S., Yukawa, T., Uetake, S. & Yamauchi, M. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Alcoholism, clinical and experimental research 31, S83\u201387, https:\/\/doi.org\/10.1111\/j.1530-0277.2006.00292.x (2007).","journal-title":"Alcoholism, clinical and experimental research"},{"key":"40322_CR24","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/ijo.2012.181","volume":"37","author":"R Rametta","year":"2013","unstructured":"Rametta, R. et al. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects. International journal of obesity 37, 986\u2013992, https:\/\/doi.org\/10.1038\/ijo.2012.181 (2013).","journal-title":"International journal of obesity"},{"key":"40322_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.metabol.2010.07.032","volume":"60","author":"T Matsunami","year":"2011","unstructured":"Matsunami, T. et al. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1\/R2) and insulin receptor substrate isoforms (IRS-1\/\u22122) of the liver in a nonalcoholic steatohepatitis animal model. Metabolism: clinical and experimental 60, 805\u2013814, https:\/\/doi.org\/10.1016\/j.metabol.2010.07.032 (2011).","journal-title":"Metabolism: clinical and experimental"},{"key":"40322_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tox.2017.11.013","volume":"393","author":"SGJ van Breda","year":"2018","unstructured":"van Breda, S. G. J. et al. Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology 393, 160\u2013170, https:\/\/doi.org\/10.1016\/j.tox.2017.11.013 (2018).","journal-title":"Toxicology"},{"key":"40322_CR27","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1096\/fj.14-256776","volume":"28","author":"D Heinrichs","year":"2014","unstructured":"Heinrichs, D. et al. Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 28, 5136\u20135147, https:\/\/doi.org\/10.1096\/fj.14-256776 (2014).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"40322_CR28","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1093\/nar\/gkq232","volume":"38","author":"J Reimand","year":"2010","unstructured":"Reimand, J., Vaquerizas, J. M., Todd, A. E., Vilo, J. & Luscombe, N. M. Comprehensive reanalysis of transcription factor knockout expression data in Saccharomyces cerevisiae reveals many new targets. Nucleic acids research 38, 4768\u20134777, https:\/\/doi.org\/10.1093\/nar\/gkq232 (2010).","journal-title":"Nucleic acids research"},{"key":"40322_CR29","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nrmicro2667","volume":"9","author":"JC Ray","year":"2011","unstructured":"Ray, J. C., Tabor, J. J. & Igoshin, O. A. Non-transcriptional regulatory processes shape transcriptional network dynamics. Nature reviews. Microbiology 9, 817\u2013828, https:\/\/doi.org\/10.1038\/nrmicro2667 (2011).","journal-title":"Nature reviews. Microbiology"},{"key":"40322_CR30","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian, A. et al. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. Cell 171, 1437\u20131452 e1417, https:\/\/doi.org\/10.1016\/j.cell.2017.10.049 (2017).","journal-title":"Cell"},{"key":"40322_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep17784","volume":"5","author":"E Shin","year":"2015","unstructured":"Shin, E., Lee, Y. C., Kim, S. R., Kim, S. H. & Park, J. Drug Signature-based Finding of Additional Clinical Use of LC28-0126 for Neutrophilic Bronchial Asthma. Scientific reports 5, 17784, https:\/\/doi.org\/10.1038\/srep17784 (2015).","journal-title":"Scientific reports"},{"key":"40322_CR32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.celrep.2012.04.006","volume":"1","author":"M Van Beek","year":"2012","unstructured":"Van Beek, M. et al. Bcl10 links saturated fat overnutrition with hepatocellular NF-kB activation and insulin resistance. Cell reports 1, 444\u2013452, https:\/\/doi.org\/10.1016\/j.celrep.2012.04.006 (2012).","journal-title":"Cell reports"},{"key":"40322_CR33","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2174\/138161212799436593","volume":"18","author":"LS Capettini","year":"2012","unstructured":"Capettini, L. S. et al. Role of renin-angiotensin system in inflammation, immunity and aging. Current pharmaceutical design 18, 963\u2013970 (2012).","journal-title":"Current pharmaceutical design"},{"key":"40322_CR34","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nature04209","volume":"437","author":"JF Rual","year":"2005","unstructured":"Rual, J. F. et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173\u20131178, https:\/\/doi.org\/10.1038\/nature04209 (2005).","journal-title":"Nature"},{"key":"40322_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbalip.2005.02.002","volume":"1734","author":"M Jove","year":"2005","unstructured":"Jove, M., Laguna, J. C. & Vazquez-Carrera, M. Agonist-induced activation releases peroxisome proliferator-activated receptor beta\/delta from its inhibition by palmitate-induced nuclear factor-kappaB in skeletal muscle cells. Biochimica et biophysica acta 1734, 52\u201361, https:\/\/doi.org\/10.1016\/j.bbalip.2005.02.002 (2005).","journal-title":"Biochimica et biophysica acta"},{"key":"40322_CR36","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2337\/db12-0570","volume":"62","author":"L Li","year":"2013","unstructured":"Li, L. et al. Telmisartan improves insulin resistance of skeletal muscle through peroxisome proliferator-activated receptor-delta activation. Diabetes 62, 762\u2013774, https:\/\/doi.org\/10.2337\/db12-0570 (2013).","journal-title":"Diabetes"},{"key":"40322_CR37","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/hr.2013.157","volume":"37","author":"D Mikami","year":"2014","unstructured":"Mikami, D. et al. Telmisartan activates endogenous peroxisome proliferator-activated receptor-delta and may have anti-fibrotic effects in human mesangial cells. Hypertension research: official journal of the Japanese Society of Hypertension 37, 422\u2013431, https:\/\/doi.org\/10.1038\/hr.2013.157 (2014).","journal-title":"Hypertension research: official journal of the Japanese Society of Hypertension"},{"key":"40322_CR38","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1161\/HYPERTENSIONAHA.109.143958","volume":"55","author":"H He","year":"2010","unstructured":"He, H. et al. Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways. Hypertension 55, 869\u2013879, https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.143958 (2010).","journal-title":"Hypertension"},{"key":"40322_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/07435800.2013.828741","volume":"39","author":"SN Yin","year":"2014","unstructured":"Yin, S. N. et al. Telmisartan increases lipoprotein lipase expression via peroxisome proliferator-activated receptor-alpha in HepG2 cells. Endocrine research 39, 66\u201372, https:\/\/doi.org\/10.3109\/07435800.2013.828741 (2014).","journal-title":"Endocrine research"},{"key":"40322_CR40","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.3892\/or.2015.3745","volume":"33","author":"Y Yoshimine","year":"2015","unstructured":"Yoshimine, Y. et al. Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis. Oncology reports 33, 1657\u20131666, https:\/\/doi.org\/10.3892\/or.2015.3745 (2015).","journal-title":"Oncology reports"},{"key":"40322_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","volume":"46","author":"M Fujii","year":"2013","unstructured":"Fujii, M. et al. A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. Medical molecular morphology 46, 141\u2013152, https:\/\/doi.org\/10.1007\/s00795-013-0016-1 (2013).","journal-title":"Medical molecular morphology"},{"key":"40322_CR42","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.clinbiochem.2017.02.023","volume":"50","author":"YJ Park","year":"2017","unstructured":"Park, Y. J., Rim, J. H., Yim, J., Lee, S. G. & Kim, J. H. Effects of two types of medical contrast media on routine chemistry results by three automated chemistry analyzers. Clinical biochemistry 50, 719\u2013725, https:\/\/doi.org\/10.1016\/j.clinbiochem.2017.02.023 (2017).","journal-title":"Clinical biochemistry"},{"key":"40322_CR43","doi-asserted-by":"publisher","first-page":"D792","DOI":"10.1093\/nar\/gkp1005","volume":"38","author":"A Spandidos","year":"2010","unstructured":"Spandidos, A., Wang, X., Wang, H. & Seed, B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic acids research 38, D792\u2013799, https:\/\/doi.org\/10.1093\/nar\/gkp1005 (2010).","journal-title":"Nucleic acids research"},{"key":"40322_CR44","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321, https:\/\/doi.org\/10.1002\/hep.20701 (2005).","journal-title":"Hepatology"},{"key":"40322_CR45","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102, 15545\u201315550, https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"40322_CR46","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk, D. et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic acids research 45, D362\u2013D368, https:\/\/doi.org\/10.1093\/nar\/gkw937 (2017).","journal-title":"Nucleic acids research"},{"key":"40322_CR47","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic acids research 44, W90\u201397, https:\/\/doi.org\/10.1093\/nar\/gkw377 (2016).","journal-title":"Nucleic acids research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40322-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40322-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40322-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T02:22:52Z","timestamp":1671243772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-40322-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["40322"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-40322-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,8]]},"assertion":[{"value":"18 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4003"}}